CAPTRUST Financial Advisors’s Tiziana Life Sciences TLSA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio TLSA Stock Details TLSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.6K	Buy	13,000 +2,000	+18%	+$2.6K	﹤0.01%	3215
2026 Q1	$12.9K	Hold	11,000	–	–	﹤0.01%	2985
2025 Q4	$16.4K	Hold	11,000	–	–	﹤0.01%	2720
2025 Q3	$23.8K	Hold	11,000	–	–	﹤0.01%	2598
2025 Q2	$17.4K	Sell	11,000 -6,000	-35%	-$8.02K	﹤0.01%	2473
2025 Q1	$18.4K	Hold	17,000	–	–	﹤0.01%	2324
2024 Q4	$11.8K	Buy	+17,000	New	+$15.7K	﹤0.01%	2277
2024 Q3	–	Sell	-34,600	Closed	-$31.8K	–	2355
2024 Q2	$31.8K	Buy	+34,600	New	+$25.3K	﹤0.01%	2166

Other funds holding TLSA

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

MAWAG

Mid-American Wealth Advisory Group Kansas City, Missouri $277M AUM 6.22% 1-Year Est. Return

Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CAPTRUST Financial Advisors's TLSA Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Tiziana Life Sciences (TLSA) stake by 18% in Q2 2026, buying an estimated $2.6K and bringing the position to 13,000 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3215.

CAPTRUST Financial Advisors first reported a position in TLSA in Q2 2024 and has held it in 8 quarters since. The position peaked at $31.8K in Q2 2024. 30 funds tracked by Wall St. Rank hold TLSA as of Q2 2026.

CAPTRUST Financial Advisors held 13,000 shares of Tiziana Life Sciences worth $16.6K as of Q2 2026.
CAPTRUST Financial Advisors bought 2,000 Tiziana Life Sciences shares in Q2 2026, an estimated $2.6K.
Tiziana Life Sciences made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #3215 holding.
CAPTRUST Financial Advisors first reported a position in Tiziana Life Sciences in Q2 2024 and has held it in 8 quarters since.
CAPTRUST Financial Advisors's Tiziana Life Sciences position peaked at $31.8K in Q2 2024.
30 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.